Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eigen Capital is a private investment firm that specializes in corporate carve-outs, complex transitions, and special situations within the life sciences, healthcare, and industrial sectors. The firm focuses on acquiring divisions of larger corporations or underperforming assets to drive operational improvements and strategic growth through hands-on management. Notable past and present portfolio companies include Celsis International, a leader in rapid microbial detection for the pharmaceutical and consumer products industries, and Clinical Supplies Management (CSM), which was carved out from Aptuit. Eigen Capital's expertise lies in scaling service-oriented businesses that provide critical infrastructure and testing solutions to the global biotechnology and pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eigen Capital Holdings.